SITAGLIVAC 50

SITAGLIVAC 50 contains Sitagliptin 50 mg, an oral antidiabetic medicine belonging to the class of DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors). It is prescribed to manage Type 2 Diabetes Mellitus (T2DM) by enhancing the body’s natural insulin response and reducing excess glucose production in the liver.

When used along with a balanced diet, exercise, and healthy lifestyle changes, SITAGLIVAC 50 helps maintain stable blood sugar levels and prevents complications associated with diabetes.

Key Benefits:

• Improves glycemic control in adults with Type 2 Diabetes

• Enhances insulin release after meals

• Reduces glucose overproduction in the liver

• Can be used as monotherapy or in combination with other antidiabetic medicines (Metformin, Sulfonylureas, or Insulin)

• Low risk of hypoglycemia compared to other diabetes medications